AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023
from Latest News https://ift.tt/2HLWMPa
Friday, 29 March 2019
AstraZeneca inks $6.9-bn breast, gastric cancer therapy deal with Daiichi
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment